<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02535273</url>
  </required_header>
  <id_info>
    <org_study_id>Tangdu-dex-loc</org_study_id>
    <nct_id>NCT02535273</nct_id>
  </id_info>
  <brief_title>The Effect of Dexmedetomidine Analgesia and Sedation in Minimally Invasive Spine Surgery Under Local Anesthesia</brief_title>
  <official_title>The Effect of Dexmedetomidine Subsidiary Analgesia and Sedation in Minimally Invasive Spine Surgery Under Local Anesthesia：A Randomized, Double Blind Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tang-Du Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tang-Du Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate safety and efficacy of dexmedetomidine in minimally invasive spine surgery under
      local anesthesia sedation.Explore the appropriate concentration of dexmedetomidine, whether
      or not can reduce the amount of local anesthetics.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ramsay sedation score</measure>
    <time_frame>From 1min before dexmedetomidine infusion to 2h after surgery，up to 4 hours</time_frame>
    <description>Evaluation time point：1min before dexmedetomidine infusion；1min before local anesthesia；lidocaine infiltrate layer by layer to the periosteum，assessed up to 2min；Intraoperative most painful moments，assessed up to 5min；1min before returning to the ward；2h after surgery.Intraoperative most painful moments：nucleus pulpous probe or Balloon Dilatation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>visual analogue scale</measure>
    <time_frame>From 1min before dexmedetomidine infusion to 2h after surgery，up to 4 hours</time_frame>
    <description>Evaluation time point：1min before dexmedetomidine infusion；1min before local anesthesia；lidocaine infiltrate layer by layer to the periosteum，assessed up to 2min；Intraoperative most painful moments，assessed up to 5min；1min before returning to the ward；2h after surgery.Intraoperative most painful moments：nucleus pulpous probe or Balloon Dilatation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The total amount of lidocaine</measure>
    <time_frame>2h after surgery；</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The patient and the surgeon satisfaction</measure>
    <time_frame>2h after surgery；</time_frame>
    <description>four grades：Very satisfied; General satisfied; Not satisfied; Very dissatisfied</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">212</enrollment>
  <condition>Spinal Diseases</condition>
  <condition>Local Anesthesia</condition>
  <arm_group>
    <arm_group_label>Low-dose Dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>load dosage：Intravenous injection dexmedetomidine 1 µg/kg，completed within 10 minutes.
Local anesthesia: lidocaine maintenance dose：Intravenous infusion of dexmedetomidine 0.3 μg/kg/min until the end of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate-dose Dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>load dosage：Intravenous injection dexmedetomidine 1 µg/kg，completed within 10 minutes.
Local anesthesia: lidocaine maintenance dose：Intravenous infusion of dexmedetomidine 0.5 μg/kg/min until the end of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High-dose Dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>load dosage：Intravenous injection dexmedetomidine 1 µg/kg，completed within 10 minutes.
Local anesthesia: lidocaine maintenance dose：Intravenous infusion of dexmedetomidine 0.7 μg/kg/min until the end of surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal saline Control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intravenous injection normal saline equal quantity，completed within 10 minutes. Local anesthesia: lidocaine Intravenous infusion of normal saline 0.125 μg/kg/min until the end of surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>load dosage：Intravenous injection dexmedetomidine 1 µg/kg，completed within 10 minutes.</description>
    <arm_group_label>Low-dose Dexmedetomidine</arm_group_label>
    <arm_group_label>Moderate-dose Dexmedetomidine</arm_group_label>
    <arm_group_label>High-dose Dexmedetomidine</arm_group_label>
    <other_name>Yisi</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>local anesthesia：0.67% lidocaine local anesthesia layer by layer to the periosteum at the puncture site，Establish puncture channel, injection 5ml 0.67% lidocaine into the vertebral body through the catheter, and observe 5-10min before operation</description>
    <arm_group_label>Low-dose Dexmedetomidine</arm_group_label>
    <arm_group_label>Moderate-dose Dexmedetomidine</arm_group_label>
    <arm_group_label>High-dose Dexmedetomidine</arm_group_label>
    <arm_group_label>normal saline Control group</arm_group_label>
    <other_name>Lidocaine Hydrochloride Injection</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Low-dose Dexmedetomidine</intervention_name>
    <description>maintenance dose：Intravenous infusion of dexmedetomidine 0.3 μg/kg/min until the end of surgery</description>
    <arm_group_label>Low-dose Dexmedetomidine</arm_group_label>
    <other_name>Yisi</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Moderate-dose Dexmedetomidine</intervention_name>
    <description>maintenance dose：Intravenous infusion of dexmedetomidine 0.5 μg/kg/min until the end of surgery</description>
    <arm_group_label>Moderate-dose Dexmedetomidine</arm_group_label>
    <other_name>Yisi</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>High-dose Dexmedetomidine</intervention_name>
    <description>maintenance dose：Intravenous infusion of dexmedetomidine 0.7 μg/kg/min until the end of surgery</description>
    <arm_group_label>High-dose Dexmedetomidine</arm_group_label>
    <other_name>Yisi</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <description>Intravenous injection normal saline equal quantity，completed within 10 minutes. Intravenous infusion of normal saline 0.125 μg/kg/min until the end of surgery</description>
    <arm_group_label>normal saline Control group</arm_group_label>
    <other_name>Sodium Chloride Physiological Solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sign the informed consent；

          -  American Society of Anesthesiologists (ASA)classification:class I~II;Elective
             minimally invasive spine surgery；

          -  Age ≥18 years old, weighing 45 ~ 80 Kg, height 151 ~ 185 cm;

          -  hypertension within Ⅱ grade, or controlled with drugs within Ⅱ level；

          -  Diabetes fasting in 8.3mol/L or less

        Exclusion Criteria:

          -  DEX allergy;

          -  Change anesthesia preoperative or intraoperative ;

          -  metabolic disorders, anemia has not been corrected;

          -  recent patients receiving sedatives and antidepressants;

          -  degenerative diseases of the central nervous elderly persons;

          -  serious central nervous system diseases (acute stroke, uncontrolled epilepsy, severe
             dementia);

          -  hypovolemia; 8) unstable angina or acute myocardial infarction;

          -  left ventricular ejection fraction less than 30%, heart rate lower than 45bpm;

          -  II-III degree heart block;

          -  acute hepatitis or severe liver disease (liver function C level);

          -  patients with renal insufficiency randomly assigned to receive treatment, but If
             patients need dialysis test is excluded or interruption ;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sun Li</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fourth Military Medical University</affiliation>
  </overall_official>
  <reference>
    <citation>Nakamura Y, Yabuki S, Kikuchi S, Konno S. Minimally invasive surgery for osteoid osteoma of the cervical spine using microendoscopic discectomy system. Asian Spine J. 2013 Jun;7(2):143-7. doi: 10.4184/asj.2013.7.2.143. Epub 2013 May 22.</citation>
    <PMID>23741555</PMID>
  </reference>
  <reference>
    <citation>Smith N, Masters J, Jensen C, Khan A, Sprowson A. Systematic review of microendoscopic discectomy for lumbar disc herniation. Eur Spine J. 2013 Nov;22(11):2458-65. doi: 10.1007/s00586-013-2848-8. Epub 2013 Jun 23. Review.</citation>
    <PMID>23793558</PMID>
  </reference>
  <reference>
    <citation>Yoshimoto M, Takebayashi T, Ida K, Tanimoto K, Yamashita T. Microendoscopic discectomy in athletes. J Orthop Sci. 2013 Nov;18(6):902-8. doi: 10.1007/s00776-013-0442-x. Epub 2013 Jul 20.</citation>
    <PMID>23873279</PMID>
  </reference>
  <reference>
    <citation>Gandhi SD, Anderson DG. Minimally invasive surgery for the lumbar spine. J Neurosurg Sci. 2012 Mar;56(1):27-34. Review.</citation>
    <PMID>22415380</PMID>
  </reference>
  <reference>
    <citation>Arts MP. Reply to the letter to the editor of R. Q. Knight concerning &quot;does minimally invasive lumbar disc surgery result in less muscle injury than conventional surgery? A randomized controlled trial&quot; by M. Arts, R. Brand, et al. (2011) Eur Spine J 20(1):51-57. doi:10.1007/s00586-012-2491-9. Eur Spine J. 2013 Apr;22(4):899. doi: 10.1007/s00586-012-2643-y. Epub 2013 Jan 9.</citation>
    <PMID>23299723</PMID>
  </reference>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 20, 2015</study_first_submitted>
  <study_first_submitted_qc>August 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 28, 2015</study_first_posted>
  <last_update_submitted>August 25, 2015</last_update_submitted>
  <last_update_submitted_qc>August 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dexmedetomidine</keyword>
  <keyword>prone position</keyword>
  <keyword>spine surgery</keyword>
  <keyword>Minimally invasive</keyword>
  <keyword>local anesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

